Advertisement

Subacute cutaneous lupus erythematosus: A facultative paraneoplastic dermatosis

      Abstract

      Subacute cutaneous lupus erythematosus (SCLE) is a photosensitive dermatosis characterized by a nonscarring papulosquamous eruption and specific antibodies in the patient's serum. Genetic and environmental factors represent the leading causes of SCLE; however, several case reports in the literature link SCLE to various types of cancer. This review assesses the association between SCLE and neoplastic disorders. A PubMed search was performed for all relevant publications on cancer-associated SCLE from 1982 to 2022. This review supports the hypothesis that SCLE should be considered a facultative paraneoplastic phenomenon. It also emphasizes the importance of cancer screening in patients presenting SCLE manifestations.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Clinics in Dermatology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Kuhn A
        • Aberer E
        • Bata-Csörgő Z
        • et al.
        S2k guideline for treatment of cutaneous lupus erythematosus - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV).
        J Eur Acad Dermatol Venereol. 2017; 31: 389-404
        • Little AJ
        • Vesely MD.
        Cutaneous lupus erythematosus: current and future pathogenesis-directed therapies.
        Yale J Biol Med. 2020; 93: 81-95
        • Li Q
        • Wu H
        • Liao W
        • et al.
        A comprehensive review of immune-mediated dermatopathology in systemic lupus erythematosus.
        J Autoimmun. 2018; 93: 1-15
        • Rothfield N
        • Sontheimer RD
        • Bernstein M.
        Lupus erythematosus: systemic and cutaneous manifestations.
        Clin Dermatol. 2006; 24: 348-362
        • Black DR
        • Hornung CA
        • Schneider PD
        • et al.
        Frequency and severity of systemic disease in patients with subacute cutaneous lupus erythematosus.
        Arch Dermatol. 2002; 138: 1175-1178
        • Kuhn A
        • Landmann A.
        The classification and diagnosis of cutaneous lupus erythematosus.
        J Autoimmun. 2014; 48-49: 14-19
        • Jatwani S
        • Hearth Holmes MP
        Subacute cutaneous lupus erythematosus.
        StatPearls. StatPearls Publishing, Treasure Island (FL)May 12, 2022
        • Okon LG
        • Werth VP.
        Cutaneous lupus erythematosus: diagnosis and treatment.
        Best Pract Res Clin Rheumatol. 2013; 27: 391-404
        • Keyes E
        • Grinnell M
        • Vazquez T
        • et al.
        Drug-induced subacute cutaneous lupus erythematosus in previously diagnosed systemic lupus erythematosus patients: a case series.
        JAAD Case Rep. 2021; 12: 18-21
        • Guhl G
        • Diaz-ley B
        • Garcia-Garcia C
        • et al.
        Chemotherapy-induced subacute lupus erythematosus.
        Lupus. 2009; 18: 859-860
        • Ben Zvi M
        • Vaknine H
        • Menczer J
        • et al.
        Gemcitabine-induced subacute cutaneous lupus erythematosus: a case report.
        Chemotherapy. 2016; 61: 236-239
        • Cornacchia MA
        • Coromilas AJ
        • Gallitano SM
        • et al.
        Subacute cutaneous lupus erythematosus induced by gemcitabine in 2 patients with pancreatic cancer.
        JAAD Case Rep. 2019; 5: 596-601
        • Fisher J
        • Patel M
        • Miller M
        • et al.
        Anastrozole-induced subacute cutaneous lupus erythematosus.
        Cutis. 2016; 98: E22-E26
        • Neumann R
        • Schmidt JB
        • Niebauer G.
        Subacute lupus erythematosus-like gyrate erythema. Report of a case associated with a breast cancer.
        Dermatologica. 1986; 173: 146-149
        • Koritala T
        • Tworek J
        • Schapiro B
        • et al.
        Paraneoplastic cutaneous lupus secondary to esophageal squamous cell carcinoma.
        J Gastrointest Oncol. 2015; 6: E61-E65
        • Evans KG
        • Heymann WR.
        Paraneoplastic subacute cutaneous lupus erythematosus: an underrecognized entity.
        Cutis. 2013; 91: 25-29
        • Gantzer A
        • Regnier S
        • Cosnes A
        • et al.
        Lupus cutané subaigu et cancer: deux cas et revue de la littérature [Subacute cutaneous lupus erythematosus and cancer: two cases and literature review].
        Ann Dermatol Venereol. 2011; 138: 409-417
        • Gama JD
        • Hashemi DA
        • Fedeles F.
        A case of paraneoplastic subacute cutaneous lupus erythematosus in a patient with metastatic melanoma.
        JAAD Case Rep. 2021; 15: 88-91
        • Achtman JC
        • Werth VP.
        Pathophysiology of cutaneous lupus erythematosus.
        Arthritis Res Ther. 2015; 17: 182
        • Cohen MR
        • Crosby D.
        Systemic disease in subacute cutaneous lupus erythematosus: a controlled comparison with systemic lupus erythematosus.
        J Rheumatol. 1994; 21: 1665-1669
        • Lu Q
        • Long H
        • Chow S
        • et al.
        Guideline for the diagnosis, treatment and long-term management of cutaneous lupus erythematosus.
        J Autoimmun. 2021; 123102707
        • Crowson AN
        • Magro C.
        The cutaneous pathology of lupus erythematosus: a review.
        J Cutan Pathol. 2001; 28: 1-23
        • Okon LG
        • Werth VP.
        Cutaneous lupus erythematosus: diagnosis and treatment.
        Best Pract Res Clin Rheumatol. 2013; 27: 391-404
        • Creative A
        • Watchmaker J
        • Maymone MBC
        • et al.
        Cosmetic treatment in patients with autoimmune connective tissue diseases: best practices for patients with lupus erythematosus.
        J Am Acad Dermatol. 2020; 83: 343-363
        • Grönhagen CM
        • Nyberg F.
        Cutaneous lupus erythematosus: an update.
        Indian Dermatol Online J. 2014; 5: 7-13
        • Blanc D
        • Kienzler JL.
        Lupus erythematosus gyratus repens. Report of a case associated with a lung carcinoma.
        Clin Exp Dermatol. 1982; 7: 129-134
        • Schewach-Millet M
        • Shapiro D
        • Ziv R
        • et al.
        Subacute cutaneous lupus erythematosus associated with breast carcinoma.
        J Am Acad Dermatol. 1988; 19: 406-408
        • Modly C
        • Wood C
        • Horn T.
        Metastatic malignant melanoma arising from a common blue nevus in a patient with subacute cutaneous lupus erythematosus.
        Dermatologica. 1989; 178: 171-175
        • McKenna KE
        • Hayes D
        • McMillan JC.
        Subacute cutaneous lupus erythematosus-like gyrate erythema and hypertrichosis lanuginosa acquisita associated with uterine adenocarcinoma.
        Br J Dermatol. 1992; 127: 443-444
        • Castanet J
        • Taillan B
        • Lacour JP
        • et al.
        Subacute cutaneous lupus erythematosus associated with Hodgkin's disease.
        Clin Rheumatol. 1995; 14: 692-694
        • Brenner S
        • Golan H
        • Gat A
        • et al.
        Paraneoplastic subacute cutaneous lupus erythematosus: report of a case associated with cancer of the lung.
        Dermatology. 1997; 194: 172-174
        • Ho C
        • Shumack SP
        • Morris D.
        Subacute cutaneous lupus erythematosus associated with hepatocellular carcinoma.
        Australas J Dermatol. 2001; 42: 110-113
        • Dawn G
        • Wainwright NJ.
        Association between subacute cutaneous lupus erythematosus and epidermoid carcinoma of the lung: a paraneoplastic phenomenon?.
        Clin Exp Dermatol. 2002; 27: 717-718
        • Chaudhry SI
        • Murphy LA
        • White IR.
        Subacute cutaneous lupus erythematosus: a paraneoplastic dermatosis?.
        Clin Exp Dermatol. 2005; 30: 655-658
        • Jasim ZF
        • Walsh MY
        • Armstrong DK.
        Subacute lupus erythematosus-like rash associated with oesophageal adenocarcinoma in situ.
        Clin Exp Dermatol. 2007; 32: 443-445
        • Torchia D
        • Caproni M
        • Massi D
        • et al.
        Paraneoplastic toxic epidermal necrolysis-like subacute cutaneous lupus erythematosus.
        Clin Exp Dermatol. 2010; 35: 455-456
        • Shaheen B
        • Milne G
        • Shaffrali F.
        Subacute cutaneous lupus erythematosus associated with breast carcinoma.
        Clin Exp Dermatol. 2009; 34: e480-e481
        • Balasubramaniam S
        • Franks A.
        SCLE: a paraneoplastic presentation.
        BMJ. 2014; 348: g2521
        • Cedeno-Laurent F
        • Obstfeld AE
        • Boni A
        • et al.
        Lupus-like eruption as the presenting sign of acute myeloblastic leukemia.
        Lupus. 2016; 25: 312-314
        • Murad A
        • O'Donnell B
        • Rowley H
        • et al.
        Subacute cutaneous lupus erythematosus: a paraneoplastic phenomenon in oropharyngeal squamous cell carcinoma.
        Clin Exp Dermatol. 2015; 40: 335-337
        • Opneja A
        • Mahajan S
        • Kapoor S
        • et al.
        Unusual paraneoplastic presentation of cholangiocarcinoma.
        Case Rep Med. 2015; 2015806835
        • Michel M
        • Comox F
        • Ollivier Y
        • et al.
        First case of paraneoplastic subacute cutaneous lupus erythematosus associated with colon cancer.
        Joint Bone Spine. 2017; 84: 631-633
        • Jenkins D
        • McPherson T.
        Paraneoplastic subacute cutaneous lupus erythematosus associated with cholangiocarcinoma.
        Australas J Dermatol. 2016; 57: e5-e7
        • Mortazie M.
        A case of paraneoplastic subacute cutaneous lupus erythematosus.
        J Am Acad D Dermatol. 2016; 74: AB78
        • Marvot M
        • Marko PB.
        Subacute cutaneous lupus erythematosus - paraneoplastic to gastric adenocarcinoma?.
        Wien Klin Wochenschr. 2017; 129: 444-445
        • Santiago L
        • Mascarenhas R
        • Tellechea Ó
        • et al.
        Toxic epidermal necrolysis-like subacute cutaneous lupus erythematosus associated with lung carcinoma.
        BMJ Case Rep. 2019; 12e231152
        • Hirner J.
        Subacute cutaneous lupus erythematosus with a possible paraneoplastic association with melanoma.
        BMJ Case Rep. 2019; 12e230558
        • Phan YC
        • Shammout S
        • Cobley J
        • et al.
        Metastatic prostate cancer presenting as subacute cutaneous lupus erythematosus.
        Australas J Dermatol. 2020; 61: e113-e114
        • Xie F
        • Frewen J
        • Divekar P.
        Three cases of subacute cutaneous lupus erythematosus associated with malignancy: a late paraneoplastic phenomenon.
        Clin Exp Dermatol. 2020; 45: 607-608
        • Kovitwanichkanont T
        • Prakash S
        • Chong AH.
        Pancreatic adenocarcinoma presenting as subacute cutaneous lupus, tripe palms and acanthosis nigricans maligna.
        Australas J Dermatol. 2021; 62: e132-e133
        • Rezazadegan R
        • Koushik-Jalali B
        • Kuntz T
        • et al.
        Paraneoplastischer subakut kutaner Lupus erythematodes [Paraneoplastic subacute cutaneous lupus erythematosus].
        Z Rheumatol. 2021; 80 ([in German]): 189-193
        • Bakar Dertlioğlu S
        • Yildiz B
        • Kiliçarslan A
        • et al.
        Subacute cutaneous lupus erythematosus: a paraneoplastic dermatosis in breast carcinoma?.
        Turk J Oncol. 2021; 36: 121-124
        • Abbott J
        • Westerdahl JS
        • Wada D
        • et al.
        Paraneoplastic subacute cutaneous lupus erythematosus with mucositis.
        JAAD Case Rep. 2022; 22: 38-41
        • Khokher W
        • Cash A
        • Alom M
        • et al.
        Subacute cutaneous lupus as a paraneoplastic manifestation of non-hodgkin lymphoma.
        J Investig Med High Impact Case Rep. 2022; 10 (23247096211063066)
        • Pipkin CA
        • Lio PA.
        Cutaneous manifestations of internal malignancies: an overview.
        Dermatol Clin. 2008; 26: 1-15
        • Silva JA
        • Mesquita Kde C
        • Igreja AC
        • et al.
        Paraneoplastic cutaneous manifestations: concepts and updates.
        An Bras Dermatol. 2013; 88: 9-22
        • Popovic K
        • Nyberg F
        • Wahren-Helenius M
        • et al.
        A serology-based approach combined with clinical examination of 125 Ro/SSA-positive patients to define incidence and prevalence of subacute cutaneous lupus erythematosus.
        Arthritis Rheum. 2007; 56: 255-264
        • Durosaro O
        • Davis MD
        • Reed KB
        • et al.
        Incidence of cutaneous lupus erythematosus, 1965-2005: a population-based study.
        Arch Dermatol. 2009; 145: 249-253
        • Ramachandran SM
        • Leventhal JS
        • Franco LG
        • et al.
        Topical drug-induced subacute cutaneous lupus erythematosus isolated to the hands.
        Lupus Sci Med. 2017; 4e000207